ROMEO, SERGIO
ROMEO, SERGIO
Dipartimento di Scienze Farmaceutiche
Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities
2023 N. Basilico, S. Parapini, S. D’Alessandro, P. Misiano, S. Romeo, G. Dondio, V. Yardley, L. Vivas, S. Nasser, L. Rénia, B.M. Russell, R. Suwanarusk, F. Nosten, A. Sparatore, D. Taramelli
γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, M. Quaglia, G. Grazioso, F. Meneghetti, S. Villa
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS.
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, G. Grazioso, M. Quaglia, F. Meneghetti, S. Villa
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, G. Grazioso, M. Quaglia, F. Meneghetti, S. Villa
From DC18 to MR07: A Metabolically Stable 4,4′‐Oxybisbenzoyl Amide as a Low‐Nanomolar Growth Inhibitor of P. falciparum
2022 I. Bassanini, S. Parapini, N. Basilico, D. Taramelli, S. Romeo
Perfluorinated probes for non-covalent protein recognition and isolation
2020 I. Bassanini, C. Galli, E.E. Ferrandi, F. Vallone, A. Andolfo, S. Romeo
In vitro characterization, structural optimization and in silico pharmacophore modeling of a new antiplasmodial chemotype
2019 I. Bassanini, S. Parapini, N. Basilico, D. Taramelli, S. Romeo
Nitric oxide releasing hyaluronic esters
2019 N. Almirante, L. Storoni, S. Romeo
Theranostic nanocages for imaging and photothermal therapy of prostate cancer cells by active targeting of neuropeptide-Y receptor
2019 I. Bassanini, V. Eleonora, S. Avvakumova, E. Galbiati, L. Sironi, C. Macchi, L. Pandolfi, M. Ruscica, P. Magni, M. Collini, M. Colombo, F. Corsi, G. Chirico, D. Prosperi, S. Romeo
Discovery and pharmacophore mapping of a new low nanomolar inhibitor of P. falciparum growth
2019 I. Bassanini, S. Parapini, C. Galli, N. Vaiana, A. Pancotti, N. Basilico, D. Taramelli, S. Romeo
Structural optimization, in vitro characterization and in silico pharmacophore modeling of a new antiplasmodial chemotype
2018 I. Bassanini, S. Parapini, N. Basilico, D. Taramelli, S. Romeo
Synthesis and antimycobacterial activity of (+)-usnic acid conjugates
2018 D. Cirillo, E. Borroni, I. Festoso, D. Monti, S. Romeo, D. Mazier, L. Verotta
Nitric oxide donating carnosine compuunds
2017 N. Almirante, L. Storoni, E. Bastia, S. Brambilla, S. Romeo
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest
2017 E. Gabriele, F. Porta, G. Facchetti, C. Galli, A. Gelain, F. Meneghetti, I. Rimoldi, S. Romeo, S. Villa, C. Ricci, N. Ferri, A. Asai, D. Barlocco, A. Sparatore
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline : A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial
2017 N. Basilico, S. Parapini, A. Sparatore, S. Romeo, P. Misiano, L. Vivas, V. Yardley, S..L. Croft, A. Habluetzel, L. Lucantoni, L. Renia, B. Russell, R. Suwanarusk, F. Nosten, G. Dondio, C. Bigogno, D. Jabes, D. Taramelli
Nitric oxide donating carnosine compuunds
2016 N. Almirante, L. Storoni, E. Bastia, S. Brambilla, S. Romeo
Gold nanocages for imaging and therapy of prostate cancer cells
2016 L. Sironi, S. Avvakumova, E. Galbiati, S.A. Locarno, C. Macchi, L. D'Alfonso, M. Ruscica, P. Magni, M. Collini, S. Romeo, G. Chirico, D. Prosperi
Theranostic nanocages for imaging and photothermal therapy of prostate cancer cells by active targeting of neuropeptide-Y receptor
2016 S. Avvakumova, E. Galbiati, L. Sironi, S.A. Locarno, L. Gambini, C. Macchi, L. Pandolfi, M. Ruscica, P. Magni, M. Collini, M. Colombo, F. Corsi, G. Chirico, S. Romeo, D. Prosperi
“Blind” targeting in action : from phage display to breast cancer cell targeting with peptide-gold nanoconjugates
2016 E. Galbiati, L. Gambini, V. Civitarese, M. Bellini, D. Ambrosini, R. Allevi, S. Avvakumova, S. Romeo, D. Prosperi
Selective and active targeting of neuropeptide Y receptors in experimental oncology: use of gold nanocages conjugated to short peptides
2015 C. Macchi, M. Ruscica, S. Avvakumova, E. Galbiati, S. Romeo, D. Prosperi, P. Magni